中文
| Catalogue |
| Recommend Products |
Company News
- AMSBIO: Easily Automated 3D Cell Culture Growth 9/15/2015
- Diverse Pharmacological Modulators for Targets, Pathways and Processes 9/1/2015
- AMSBIO: Adeno-Associated Virus Services for Gene Delivery 8/25/2015
- Ultimate Control for Immunohistochemistry and in situ Hybridisation 7/28/2015
- AMSBIO: Protein Delivery Reagent Assists Neurodegeneration Research 7/17/2015
- AMSBIO announces GMP Grade Cell Cryopreservation Media 6/17/2015
- AMSBIO: Ready-to-Use Tagged cDNA Clones 6/1/2015
- AMSBIO: Organoid Biobank for Predicting Cancer Patient Response to Drugs 5/27/2015
- AMSBIO:Xeno-Free and Endotoxin-Free Human Cytokines 5/4/2015
- Exclusive Biotinylated Protein Collection Specially Designed to Simplify Your Research 4/27/2015
- AMSBIO:Guide to Organoid Growth 4/1/2015
- AMSBIO: New tools and services for Immunotherapy discovery 3/20/2015
- AMSBIO: High Efficiency mRNA Delivery 3/3/2015
- AMSBIO: High Throughput PARP in vivo Pharmacodynamic Assay 2/27/2015
- AMSBIO: Novel Organoid Matrix Enables Long-Term Culture of Human Hepatocytes 2/2/2015
- AMSBIO: Specificity-Verified Monoclonal Antibodies 1/16/2015
- AMSBIO: Ebola Antigens and Antibodies for ELISA 12/19/2014
- AMSBIO: Highly Efficient Neuro Transfection Reagent 12/11/2014
- AMSBIO: Consistent Embryoid Body Formation and Differentiation from Stem Cells 12/2/2014
- AMSBIO Signs Agreement with Luxcel Biosciences to distribute Fluorescence-based Mitochondr... 11/13/2014